Zobrazeno 1 - 10 of 11 pro vyhledávání: '"Jean Fred Colombel"'
1
Appropriateness of Testing for Anti–Tumor Necrosis Factor Agent and Antibody Concentrations, and Interpretation of Results
Autor: Fernando Velayos, Gilaad G. Kaplan, Shane M. Devlin, Leonard Baidoo, Marla Dubinsky, Miles P. Sparrow, Diane R. Mould, Jean Fred Colombel, Adam S. Cheifetz, Brian Bressler, Niels Vande Casteele, Peter M. Irving, Gil Y. Melmed, Laura E. Raffals, William J. Sandborn, Patricia Kozuch, Jennifer Jones, Corey A. Siegel
Publikováno v: Clinical Gastroenterology and Hepatology. 14:1302-1309
Background & Aims The availability of tests for blood concentrations of anti–tumor necrosis factor (TNF) agents and antibodies against these drugs could improve dose selection for patients with inflammatory bowel disease (IBD). However, there is li
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbbe28ca9c163dd9a0dd1c8534db5c13
https://doi.org/10.1016/j.cgh.2016.05.010
Zobrazit plný text záznamu
3
HealthPROMISE: Utilization of Patient Reported Outcomes to Measure Quality of Life in Inflammatory Bowel Disease
Autor: Thomas A. Ullman, Bruce E. Sands, Rivelle Zlatopolsky, Ed Berde, Steven H. Itzkowitz, Emamuzo Otobo, Jason Rogers, Laurie Keefer, Jean-Fred Colombel, James F. Marion, Ashish Atreja, Pavan Choksi, Helena Chang, Akshay Kohli, Karthik Ramireddy, Allyssa Deorocki
Publikováno v: Iproceedings. 3:e28
Background: Inflammatory Bowel Disease (IBD) is a chronic condition of the bowel affecting over 1.5 million people in the United States. The recurrent nature of IBD makes affected patients ideal candidates for electronic patient reported outcome (e-P
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5b5f2aa3242e69fac33126c0dc0b16f0
https://doi.org/10.2196/iproc.8452
Zobrazit plný text záznamu
4
Impact of the Mobile HealthPROMISE Platform on the Quality of Care and Quality of Life in Patients With Inflammatory Bowel Disease: Study Protocol of a Pragmatic Randomized Controlled Trial
Autor: Nishant P Patel, Thomas A. Ullman, Sameer Khan, Shirley M. Moore, Ashish Atreja, Emamuzo Otobo, Jason D Rogers, Bruce E. Sands, Jean Fred Colombel
Publikováno v: JMIR Research Protocols
JMIR Research Protocols, Vol 4, Iss 1, p e23 (2015)
BackgroundInflammatory bowel disease (IBD) is a chronic condition of the bowel that affects over 1 million people in the United States. The recurring nature of disease makes IBD patients ideal candidates for patient-engaged care that is centered on e
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da18fdbe2328099f23ee25d187bb0327
https://doi.org/10.2196/resprot.4042
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje